Structure (Sevelamer Carbonate Tablets 1)
Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 65162-058
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 65162-058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
2 (Sevelamer Carbonate Tablets 2)
This appears to be a tabular data with some statistical analyses involving screening BSA, baseline serum phosphorus and Sevelamer Carbonate and placebo treatments. It is not possible to provide a comprehensive description as the text lacks context and sufficient information.*
F-2 (Sevelamer Carbonate Tablets 3)
F-3 (Sevelamer Carbonate Tablets 4)
10 (Sevelamer Carbonate Tablets 5)
Each film-coated tablet contains Sevelamer carbonate as an active ingredient along with diacetylated monoglycerides, hypromellose, microcrystalline cellulose, silicon dioxide and zinc stearate as inactive ingredients. Imprinting ink contains ammonium hydroxide, iron oxide black, propylene glycol and shellac. Dosage information is available in the package insert. It is advised to store the tablets at a temperature of 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The tablets are manufactured by Amneal Pharmaceuticals Put. Ltd. and distributed by Amneal Pharmaceuticals LLC. The packaging should be airtight and protected from moisture.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
